Biomarker analysis of coBRIM: Phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma | Prof Grant McArthur
At the European Cancer Congress (ECC) 2015, Grant McArthur, MBBS, BMedSc, PhD, FRACP, of the Peter MacCallum Cancer Centre, Victoria, Australia, discusses the impact of baseline genetic heterogeneitie...
Author: EMJ
Added: 11/17/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts